top of page

F.D.A. Grants Full Approval to Pfizer-BioNTech Covid Vaccine

The United States Food and Drug Administration (F.D.A) granted full approval to Pfizer-BioNTech's COVID-19 vaccine for people sixteen years of age and older — making the vaccine the first to receive full authorization in the U.S.

The F.D.A's landmark decision will allow hospitals, academic institutions, and more entities to mandate the vaccine. In May 2021, the state of New York announced that all students that are attending in-person learning at State Universities of New York and City University of New York schools will be required to be vaccinated.

This morning, President Biden tweeted this statement, regarding the F.D.A's approval, and plans to address the approval in detail during a speech this afternoon.

The largest vaccination campaign is currently underway. In the U.S. 428,531,345 total vaccines have been delivered and 362,657,771 vaccines have been administered — as of Sunday, August 22, 2021, 3:03 P.M. ET. On a global scale, 32.5%of the world population has received at least one dose of a COVID-19 vaccine, and2 4.5% is fully vaccinated. 4.97 billion doses have been administered globally, and 34.91 million are now administered each day. Only 1.4% of people in low-income countries have received at least one dose — as of Monday, August 23, 2021, 7:15 A.M. ET.


Keep up with the latest COVID-19 vaccine news

Articles, here

U.S. rollout, here

Worldwide rollout, here


bottom of page